Injection device

ABSTRACT

The invention relates to a needle delivery device comprising a device body; one or more skin pinching members attached to the device body, the skin pinching members being moveable to pinch a longitudinal fold of skin of a patient. The device also comprises a drive mechanism configured to drive a needle out of the device body and along a needle path into the longitudinal fold of skin pinched between the pinching members, and subsequently withdraw the needle, the needle path extending substantially parallel to the surface of the patient.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation application of U.S. patentapplication Ser. No. 16/759,274, filed Apr. 24, 2020, which is aNational Stage Application of PCT/GB2018/053108, filed Oct. 26, 2018,which claims the benefit of and priority to Great Britain PatentApplication No. 1717647.0, filed Oct. 26, 2017, the entire contents ofwhich are incorporated herein by reference.

This invention relates to an injection device.

It is known to deliver drugs through the skin, i.e. transdermally, byusing a needle in conjunction with a delivery device.

These devices can be complex, cumbersome and expensive.

Many drugs, in particular biologics have low potency or generallyrequire large volumes to be administered by injection. Delivery of largevolumes of drugs by injection often requires body-worn devices to enablethe drug to be injected over an extended period of time. Concentratingthe drug to reduce the volume and making it more viscous poseschallenges such as irritation, and the need for substantial injectionforces. Body worn devices allow large volumes to be injected overperiods ranging from 10's of minutes to several hours. However, bolusdoses are required to be administered as rapidly as possible, to ensurethe correct plasma drug concentrations can be reached, hence it ispreferable to deliver bolus doses very rapidly.

It is preferable therefore to have a device that can inject a largevolume of drug as a bolus, very rapidly, within a few minutes. Thisinvention describes means of achieving this.

According to the present invention, there is provided a needle deliverydevice comprising: a device body;

-   -   one or more skin pinching members attached to the device body,        the skin pinching members being moveable to pinch a longitudinal        fold of skin of a patient; and a drive mechanism configured to        drive a needle out of the device body and along a needle path        into the longitudinal fold of skin pinched between the pinching        members, and subsequently withdraw the needle, the needle path        extending substantially parallel to the surface of the patient.

The needle device preferably comprises a pharmaceutical compositiondelivery mechanism configured to deliver a pharmaceutical compositionthrough the needle.

Optionally, the needle path within the device body changes direction asit leaves the device body.

Preferably, the needle delivery device comprises at least one needle.The device can also comprise multiple needles. Advantageously, at leasta portion of the at least one needle can be flexible.

The needle delivery device can also further comprise a guide memberconfigured to guide the at least one needle along the needle path. Inaccordance with one aspect, the guide member is, or includes, a roller.

Preferably, the at least one needle is configured to revert to anelongated straight shape after passing through an arcing pathway.

In accordance with one aspect of the invention, when positioned withinthe device body the at least one needle is covered by a protectivesheath. The protective sheath has a rigid section and a flexiblesection, wherein the rigid section surrounds the tip of the at least oneneedle and comprises an opening to allow the at least one needle to exitthe rigid section on actuation of the drive mechanism.

Optionally, the protective sheath comprises a sealing membrane coveringthe opening, wherein the sealing membrane is penetrable by the at leastone needle.

In accordance with the present invention, the at least one needle has alength of greater than about 12 mm, preferably from about 20 mm to about200 mm, more preferably from about 20 mm to about 100 mm, morepreferably from about 20 mm to about 50 mm.

Preferably, the needle delivery device comprises a pharmaceuticalcomposition reservoir in fluid communication with the pharmaceuticalcomposition delivery mechanism.

Advantageously, the needle delivery device can further comprise a sensormechanism to sense the pinching of the longitudinal fold of skin.

In accordance with one embodiment there is provided a method ofadministering a pharmaceutical composition to a patient comprising usinga needle delivery device of any preceding claim. Preferably, thepharmaceutical composition is delivered as the at least one needle isbeing retracted through the pinched skin.

In a further aspect of the present invention there is provided a devicefor pinching the skin comprising:

-   -   a device body;    -   one or more skin pinching members attached to the device body,        the skin pinching members being moveable to pinch a longitudinal        fold of skin of a patient; and sensing means to sense the        pinching of the longitudinal fold of skin.

Preferably the device further comprises:

-   -   a drive mechanism configured to, in use, drive a needle out of        the device body and along a needle path into the longitudinal        fold of skin pinched between the pinching members, the needle        path extending substantially parallel to the surface of the        patient; and a pharmaceutical composition delivery mechanism        configured to deliver a pharmaceutical composition through the        needle.

Advantageously, the sensing means comprises at least one light sourceand at least one light sensor to detect the presence of pinched skintherebetween.

Alternatively, or in addition to the light sensor, the sensing meanscomprises at least one mechanical switch to detect contact with pinchedskin.

The sensing means can comprise an electrical sensor to detect contactwith pinched skin.

Preferably, the sensing means is a pressure sensor.

The sensing means can comprise a plurality of sensing means to detectpinching along the length of the longitudinal fold of pinched skin.

In one aspect of the invention, the skin pinching member(s) areconfigured to automatically adjust based on the volume of thepharmaceutical composition injected into the skin; or wherein the skinpinching member(s) are configured to automatically adjust using pressuresensors based on the pressure of the pinched skin.

In accordance with one aspect of the invention there is provided amethod of sensing the pinching of a longitudinal fold of skincomprising;

-   -   placing a device as described above in contact with the skin of        a patient; moving at least one skin pinching member to pinch a        longitudinal fold of skin;    -   sensing the pinching of the longitudinal fold of skin.

The method can further comprise the steps of:

-   -   driving at least one needle out of the device body and along a        needle path into the longitudinal fold of skin pinched between        the pinching members, the needle path extending substantially        parallel to the surface of the patient; and    -   delivering a pharmaceutical composition to the patient through        the at least one needle as the needle is being withdrawn through        the longitudinal fold of skin.

The present invention will now be described with reference to thefigures, in which

FIG. 1A is a plan view of a needle delivery device.

FIG. 1B is a plan view of another needle delivery device.

FIG. 2 is a cross section schematic of a needle delivery device showinga drug reservoir longitudinal to the needle.

FIG. 3A is a front cross section of the device before activation.

FIG. 3B is a front cross section of the device after activation.

FIG. 3C is a front cross section of another device after activation.

FIG. 4A is a side cross section of a device with a flexible needle.

FIG. 4B is a side cross section of a device with a flexible needle afteractivation.

FIG. 5A is a schematic arrangement of a needle with a protecting cover.

FIG. 5B is a schematic view of the sheathed needle schematic in activeposition.

FIG. 6 is a schematic of a guide track for the needle/sheath.

FIG. 7A is a schematic illustration of a mechanism for operating theskin pinch member before activation.

FIG. 7B is a schematic illustration of a mechanism for operating theskin pinch member after activation.

FIG. 8A is a schematic illustration of another mechanism for operatingthe skin pinch member before activation.

FIG. 8B is a schematic illustration of another mechanism for operatingthe skin pinch member after activation.

FIG. 9A is a schematic view of a skin pinching member engagementmechanism.

FIG. 9B is a schematic view of another skin pinching member engagementmechanism.

FIG. 10 is a cross sectional view of skin against a needle exit port.

FIG. 11 is a cross sectional view of the device showing optical sensors.FIG. 12A is a cross sectional view of the device showing mechanicalsensors.

FIG. 12B is a cross sectional view of the device showing activatedmechanical sensors.

FIG. 13A is a schematic perspective view of the device.

FIG. 13B is a schematic front view of the device.

A device and method are described for injecting large volumes of drugsrapidly in a controlled manner, to either negate the need for abody-worn device or to minimise the duration of wear time required of abody worn device. The device pinches a longitudinal portion of the skin,creating a skin volume within which a needle can be inserted. The needlecan then be gradually drawn away from the skin, whilst depositingcontinuous or intermittent drug volumes as the needle is drawn out ofthe skin, enabling a large volume to be distributed using single ormultiple needles to within a precise depth within the skin, rapidly.

This invention relates to a device and method for rapidly injecting druginto the skin, in particular the invention relates to injecting drugformulations within the dermis or subcutaneous layer, or layers that donot reach the intramuscular tissue. Injecting a large volume requiresthe drug volume to disperse within the tissue, and this can only occurat a certain maximum rate, based on the local tissue circulation andintracellular uptake. Very rapid injection forces will lead tocollateral damage of tissue, and bruising and inflammatory reactionshence it is preferable not to inject with very high forces to increasethe delivery time.

Often the skin is pinched manually by the user to raise the tissue andallow the needle to be inserted.

This invention describes a method for pinching the skin over alongitudinal distance such that a significantly larger volume isavailable for the insertion of a significantly longer needle. It isintended that the needle would first penetrate thelongitudinally-pinched region of the skin to a maximum distal position.The drug formulation would then be injected either at a constant forceor intermittently as the needle is withdrawn, thus allowing a largevolume of the drug to be injected over a larger skin volume at a rapidspeed.

Normally 1 ml of drug can be injected into subcutaneous tissue within aperiod of 10-15 seconds. A volume of up to 20 ml would therefore requireseveral minutes for administration, often over 30 minutes, since when aneedle is inserted and a volume of for example 1 ml is injected, thelocal tissue is only able to take up 1 ml of the drug volume, and anyfurther volume uptake in that specific region will lead to back flow,blockages in the needle, back pressure build-up, and tearing ofintracellular tissue leading to tissue damage and bruising. It is notpossible therefore to inject 10 ml in for example 100 to 150 seconds andthe rate of injection flow may have to be reduced to less than 0.5 mlper minute to ensure the entire volume can be adequately taken up by thetissue.

However, the present invention allows the needle to be graduallyretracted into new tissue space, allowing the faster delivery of a largevolume of material to a patient. Therefore, as an example of using theinvention, if 1 ml takes 10 seconds to inject, then 10 ml will take 100seconds to inject.

This requires a needle that has sufficient rigidity to be inserted atlonger depths of up to several centimetres. For example, an averagesubcutaneous injection needle is between 4 mm and 12 mm. However, in thepresent invention the needle may be as long as 100 cm or possibly longerdepending where the device is applied. Such needle lengths have not beenused for subcutaneous injections as standard practice.

In order to allow the needle to be inserted in the correct layer oftissue, e.g., fat layer, dermis, or subcutaneous layer, the needle musttherefore be inserted into the skin horizontally and not vertically orat an angle to the skin. This is achieved by pinching the skin along alength that is greater than the intended distance of insertion of theneedle, sufficiently that when the drug is injected it is retainedwithin the skin. The needle is injected substantially parallel to thesurface of the skin, after the skin is pinched to a height and lengthadequate for needle insertion, and the needle height relative to thepinched tissue may be adjusted to provide skin penetration to thedesired tissue depth.

The pinching action may achieve one of a number of objectives:

-   -   Hold the skin in a loose pinched position to enable the drug        volume to be injected along the length of the skin as the needle        is retracted.    -   Pinch the skin tightly creating a longitudinal compressed region        of the skin where there is a temporary hiatus in the blood        supply and compression on nerve endings thus minimising the        sensation of pain. This higher degree of constriction may be        released once the needle has been inserted to the full distance,        to enable a large volume of drug to be inserted without        constricting the flow of the drug volume into the tissue.

An important feature of the pinching action is to ensure the skin isuniformly pinched along the entire length to avoid potential problems.For example, if a needle is inserted into tissue that is not uniformlypinched, the needle could exit the skin and re-enter further along,potentially causing injury as well as leading to loss of drug volume tothe exterior of the skin. Indeed, in the event of normal (prior art)pinching of the skin for a subcutaneous injection, if the needle wasinserted horizontally along the plane of the skin/body, the needle wouldprotrude from the other side of the pinched tissue.

The uniformity of the skin pinching can be achieved using a number ofmethods:

-   -   A mechanical barrier is positioned, in the form of a        longitudinal groove within which the skin is pinched, such that        the pinched skin takes the shape and volume of the groove/hollow        chamber formed within the mechanical barrier.    -   An optical detection method is used, for example using an LED        and a diode to transmit light and detect the transmitted light,        respectively. The skin pinching will only be deemed to have been        successfully uniformly undertaken when light cannot be detected        by the diode across the designated length of pinched tissue,        when the skin is adequately and uniformly pinched. In the event        light still passes to the detector the pinching action will        occur again until no light passes through, as will be described        below with reference to the figures.    -   A series of mechanical switches positioned at the roof of the        hollow chamber/groove, whereby each and every switch must be        mechanically activated to confirm that the skin has been        adequately pinched uniformly across the entire cross section.

In a further embodiment of the invention, in particular for very largevolumes being injected, the pinching member(s) may be relaxed across theentire length of the skin, or towards the distal region of the skin/tipend of the needle, either in a single step or gradually, as the drugvolume is being injected, in order to accommodate the increase in volumeof the skin. The relaxing of the skin pinching member(s) may bepre-determined and automatically adjusted based on the volume injectedfor a given length, based on pre-determined increased in the skinvolume, or it may be determined using pressure sensors against the roofand/or inner walls of the pinching member(s), whereby as the pressureexceeds a pre-determined value the pinching member is adjusted/relaxedto maintain the pressure at a given predetermined maximum value.

Turning to FIG. 1 , a needle delivery device is shown having a devicebody 6. A pair of skin pinching members 1 are shown on the underside ofthe device, comprising two elongate bars that are generally parallel toeach other.

In use, the device is placed in contact with the skin of a patient andthe pair of skin pinching members 1 are moved towards each other. Indoing so, they pinch a longitudinal fold of skin between them, along thelength of the skin pinching members. The terms skin, or a fold of skin,are used here to refer to the outer tissue of the patient's body. So, afold of skin also encompasses a fold of skin and some underlying tissuesuch as subcutaneous fat.

In the embodiment shown in FIG. 1 , the device comprises two skinpinching members 1 which are both attached to the device body and areboth moveable towards each other. In other embodiments, the device maycomprise a first fixed pinching member and a second moveable pinchingmember which is moveable towards the first pinching member. This mayinclude embodiments where the fixed pinching member is formed by part ofthe device body 6, which remains fixed and the other member moves topinch the skin against the fixed side.

The device includes a pharmaceutical composition reservoir 2,pharmaceutical composition reservoir exit port 3, which may be a luerslip or luer lock or other connection means, via which thepharmaceutical composition is forced out of the reservoir 2. The plunger(in the case of the pharmaceutical composition reservoir being apre-filled cartridge or syringe) is not shown here, neither is any othermode of forcing the drug out of the reservoir, and these such mechanismsare generally well understood in the state of the art. A needle hub andassociated needle drive mechanism 5, are indicated together with anelectronic control board 4 where the device is intended to beelectro-mechanical rather than purely mechanical.

As mentioned above, in use the device forms a longitudinal fold of skinbetween the skin pinching members 1. The needle drive mechanism thendrives the needle out of the device body 6 and into the formed fold ofskin. As the needle passes out of the device body 6 and into the fold ofskin it travels along a needle path that is substantially parallel tothe surface of the patient. This allows the needle to penetrate throughthe fold of skin to a predetermined distance, whilst being kept to acontrolled depth within the fold of skin.

The pharmaceutical composition delivery mechanism then delivers thepharmaceutical composition from the reservoir through the needle andinto the patient. As mentioned above, delivering the composition as theneedle is being withdrawn through the length of the fold of skin isadvantageous as it allows for the rapid delivery of a large volume ofmaterial. The pharmaceutical composition can be delivered to the patientusing a variety of methods, such as via a plunger mechanism that forcesthe contents of the reservoir (e.g. a vial or pre-filled syringe)through the bore of the needle. Where alternative collapsible reservoirsare used, containing a fluid communication connection with a suitablymounted needle, the contents of the reservoir may be dispensed bycompressing the reservoir leading it to collapse as the content isexpelled.

FIG. 1B shows a plan view of another embodiment of the device, with aneedle hub overlapping the skin pinch members 1. So, unlike the deviceshown in FIG. 1A, this device has the needle drive mechanism locatedabove the skin pinching members 1, rather than being located to one sideof the skin pinching members 1.

The overlapping of the skin pinch member 1 by the needle hub 5 ensuresthat the skin is adequately compressed against the hub and unable to bedisplaced by any significant amount, allowing the needle to adequatelypenetrate the skin at the desired depth.

FIG. 2 shows a cross-sectional side view of the device showing theneedle drive mechanism 5 to one side of the skin pinching members 1. Thedrug reservoir 2 is located directly above the needle drive mechanism 5.and generally perpendicular to the skin pinching member 1. An upperregion 13 is indicated within body 6 of the device, in the vicinity ofthe pinching members 1. The region 13 is provided with sensing means toconfirm the uniformity of the skin pinch across the length of the skinpinching member, prior to insertion of the needle into the skin. Thesensing means may comprise optical, mechanical and/or electrical sensorslocated in the region 13. It is advantageous to be able to sense ordetermine the uniformity of the longitudinal fold of skin.

FIG. 3A is a front cross section of the device showing the skin pinchingmembers 1 end on within the body 6 of the device. The location of thepinching members 1 is shown relative to the device housing 6, and skin7. This is the situation as the device is placed on the skin 7 of thepatient but before the skin pinching members are moved towards eachother. FIG. 3B shows a front cross section of the device after the skinpinching members have been activated. The skin pinching members 1 havemoved inwards to pinch the skin 7 within the groove/chamber between theskin pinching members 1 beneath the body 6 of the device, showing thecross section of a raised area of skin, which will be uniform across thelength of the skin pinching member. In this embodiment, the outer casing6 is shown to be stationary relative to the skin pinch members 1,whereby the latter expands inwards or is moved inwards to pinch theskin.

FIG. 3C is a front cross-sectional view of the device showing the skinpinching members and the wall of the device body 6 moving in tandem. Theembodiment shown in this figure differs from that shown in FIG. 3B asthe outer casing also moves in with the skin pinch member 1, which maybe preferable as a visual confirmation for the user that the skin pinchis complete.

FIG. 4A shows a longitudinal cross section schematic showing the skin 7in a raised pinched state, within the chamber between the skin pinchmembers 1. A needle connection port 9 is shown connected to aflexi-rigid needle, whereby the flexi section 10 of the needle isconnected directly to a rigid section 8, shown in a stationary position.The rigid section 8 of the needle can pass through compressing guiderollers 11 and single large guide roller 12 to force the needle tofollow an arcing pathway. The flexi portion 9 of the needle may beproduced from a thin walled flexible metal, or polymer such as polyvinylacetate, polypropylene, or one of many other polymers known in the stateof the art. The rigid section 8 may be produced from a plastic polymertoo, though it is preferably produced from a metal such as stainlesssteel, or a shape memory metal such as nickel titanium, whereby themetal is rigid in that it maintains its elongated straight shape, but isable to pass through rollers through an arching pathway before revertingto a straight rigid position. The use of needles that comprise aflexible portion enables the device to be compact. The needle isdirected through an opening in the body 6 of the device and then outtowards the fold of skin.

Flexible needles can be produced to allow a 90 degree bend radiuswithout fracturing or permanently deforming the needle. Such needles maybe formed using metal alloys such as nickel titanium, stainless steelmetals of very high aspect ratio, other inert metals, polymers such asnylon and polyester and medical grade polymers widely used in theconstruction of syringes. Flexible needles made from these materialswould normally be produced through an extrusion mechanism. A combinationof a metal tip and plastic body/conduit may also be used to form aflexible needle, wherein the metal tip provides a sharp mechanicallystrong leading tip. Flexible needles may be as small as 10's of micronsthin, such as hollow fiber optic cables, through to standard 18 gauge atthe tip, with equivalent or different diameter flexible conduitconnected to the reservoir via a luer slip or luer lock connection, viawhich the drug may flow from the reservoir.

The needles used can be flexible along a portion or along all of itslength. The needle may be formed from using metal alloys such as nickeltitanium, stainless steel metals of very high aspect ratio, other inertmetals, polymers such as nylon and polyester and medical grade polymerswidely used in the construction of syringes. The needle can be formedthrough an extrusion process.

The needle 120 may instead have a flexible portion (e.g. a plasticbody/conduit) and a rigid metal tip, such as that described hereinabovewith reference to the first needle delivery device 10.

The drive mechanism may be mechanically operated using a series ofrollers, pulleys and suitably mounted springs, or it may beelectromechanically driven using actuators such as a combination ofmotors and gears, or linear actuators such as those constructed fromshape memory metals.

The pharmaceutical composition reservoir is in fluid communication withan end of the needle. This may be a direct fluid communication or anindirect fluid communication via an intermediate member which permitssuch fluid communication. For example, there may be a flexible conduitconnected at one end of the reservoir via a luer slip or luer lockconnection, and at the other end to the needle.

FIG. 4B is a schematic view of the device shown in FIG. 4A in anactivated position showing the needle 8 passed through the guide rollers11 and 12, out of the device body 6 and into the longitudinal fold ofthe skin 7.

FIG. 5A is a schematic view of a needle with a protecting cover orsheath suitable for use in the invention. The connecting hub 9 of theneedle is shown connected to the flexi portion of the needle 10, whichin turn is directly connected to the rigid portion of the needle 8. Therigid portion 8 includes the needle tip that is intended to penetratethe skin. The needle tip is shrouded in a rigid section 14 of a sheath,with a needle sheath tip section 15 that is penetrable by the needle,encased by rigid walls of the sheath tip region 16, and aflexi-compressible and collapsible sheath 13 section. The flexi sectionof the needle 10, allows the rigid section to be moved along a distancewithout requiring the entire needle to be rigid which would requiresubstantially more space to accommodate.

The compressible and collapsible sheath serves two functions. Firstly,to enable the needle to be guided through the guide rollers 11 (notshown here), by allowing the guide rollers 11 to compress against therigid section of needle 8 itself rather than just compressing the sheathwhich would lead to just the sheath being pulled across through theguide rollers (since all needle sheaths are generally rigid plasticmaterials). Secondly, to enable the needle to pass through thepenetrable sheath tip 15, and by doing avoiding the need for the user tohave to remove the protective sheath around the needle during use. Whenthe needle has been used and retracts back to its rest position theneedle tip will return back within the rigid portion of the protectivesheath thus preventing any needle stick injuries.

FIG. 5B is a schematic illustration of the penetration of the needle tipthrough the sheath and indicates the guide rollers 11 compressingagainst the needle and not restricted by the sheath outer wall 13, whichis compressed by the guide rollers. Reference 13 a indicates the sheathcollapsing against the end of the needle sheath tip as the needle movesout of the sheath.

FIG. 6 is a schematic view of the guide track for the needle/sheath.This figure illustrates the guide track within which the needle andassociated needle sheath pass through, showing a rigid wall with opening15, whereby the needle sheath 13 will not be able to pass beyond therigid wall with opening 15. However, the needle tip will at this pointemerge past the sheath rigid tip wall 16, through the opening 15allowing the collapsible and compressible sheath section to collapse asthe needle exits the sheath.

FIGS. 7A and 7B are schematic illustrations of one mechanism foroperating the skin pinching members, showing the rest position (A) andactive position (B). A compressible section 17 is linked to two arms 18in a scissor like manner, such that when the compressible section iscompressed the tips of the arms come closer together, and in theprocess, pinch the skin.

FIGS. 8A and 8B are schematic illustrations of one mechanism foroperating the skin pinching members, showing the rest position (A) andactive position (B). A cam mechanism 19 is depicted for the activationof the skin pinching members 1. Rotation of the cam mechanism moves theskin pinching members towards each other.

FIGS. 9A and 9B show possible ways for the skin pinching members toengagement the skin of the patient. FIG. 9A shown an adhesive portion 20that holds the skin pinching members 1 adhered to the skin, whereas FIG.9B illustrates a mechanical tip region that engages the skin, thepurpose being to restrain the skin firmly whilst the skin pinch memberis activated. In the case of the adhesive any pressure sensitiveadhesive such as silicone, acrylic or synthetic rubber type adhesivesmay be used.

FIG. 10 is a cross section of the patient's skin against a needle exitport. The cross-section schematic shows a fold of skin 7 fitting withina chamber of the device between the needle pinch member, in the activeposition, where the skin 7 is raised and fits to conform to the shapeand volume of the chamber. The skin 7 also rests against the terminalportion of the rigid needle sheath housing 15, through which the needlewill protrude and penetrate in to the skin.

The skin is firmly held in place to ensure the needle can pierce theskin without the skin giving way and moving out of position which maylead to the needle penetration the skin at an incorrect depth. The pinchmechanism will therefore ensure the skin is pressed against the sheathtip 15, and this may be achieved by ensuring the skin pinch memberoverlaps with the region where the needle tip and associated rigidsheath is positioned. This ensure that there is extra skin pinched tofill the chamber between the skin pinch member, since if the skin pinchmember is short of the tip of the needle, and not overlapping, then theskin in that latter region may not be adequately under tension and maygive way when the needle starts to penetrate it.

FIG. 11 is a cross sectional view of a device showing optical sensors.The skin 7 is shown in the pinched position by the skin pinching members1. The device also comprises optical sensors 22 interspersed across thelength of the pinch members to detect and ensure that the skin is evenlypinched. A standard light emitting diode available widely, and suitablephoto diode to detect the light is positioned and the electronicfeedback will prevent the drug being injected until all the diodes areobscured by the skin.

FIGS. 12A and 12B are cross sectional views of a device showing opticalmechanical detection of skin pinch uniformity. Mechanical switches 23are shown in the roof of the chamber within which the skin gathers as itis pinched, shown in the rest position (A) and activated position (B).Contact of the fold of skin against the mechanical switches indicatesthe correct pinching of skin.

FIG. 13A shows a perspective view of a device of the invention and FIG.13B shows a front view of a device of the invention, indicating thelongitudinal nature of the device. The device body 6 is shown beingplaced on the skin 7 of the patient, with the skin pinching members 1spaces wide apart before activation.

Upon activation, the skin pinching members 1 are moved towards eachother, creating a fold of skin tissue 7 therebetween. A longitudinalfold of skin 7 is thus formed along the length of the skin pinchingmembers 1.

-   -   1 longitudinal skin pinch member    -   2 Drug reservoir    -   3 drug reservoir distal/exit end with luer slip or luer lock        connection port    -   4 Electronic control box    -   5 Needle hub mechanism accommodating the flexible needle    -   6 Outer housing of injector device    -   7 skin    -   8 bendable rigid needle    -   9 connection port on flexi-rigid needle    -   10 flexi portion of needle    -   11 compressing guide rollers for needle    -   12 single large guide roller for needle    -   13 Needle sheath/protecting cover-flexi-rigid/compressible    -   14 rigid portion with narrow needle locating orifice within        flexi-rigid/compressible needle sheath    -   15 terminal portion of needle sheath penetrable by needle    -   16 rigid guide wall of terminal portion of needle sheath    -   17 contracting mechanism for longitudinal skin pinching member    -   18 skin pinching member pinching arms    -   19 Cam mechanism for operating skin pinching member 1    -   20 Adhesive for gripping skin    -   21 mechanical protrusion for gripping skin    -   22 optical detection mechanism for skin pinching consistency    -   23 mechanical switch detection mechanism for skin pinching        consistency

1-28. (canceled)
 29. A needle delivery device comprising: a device body;one or more skin pinching members attached to the device body, the oneor more skin pinching members being moveable to pinch a longitudinalfold of skin of a patient, wherein the one or more skin pinching membersincludes an inner surface which contacts a side of the longitudinal foldof skin upon movement of the one or more skin pinching members to createthe longitudinal fold of skin; and a drive mechanism configured, in use,to drive a needle along a needle path, into the longitudinal fold ofskin pinched between the pinching members, and subsequently withdraw theneedle, the needle path extending within the device body, passing out ofthe device body and extending substantially parallel to the longitudinalfold of skin; and at least one sensor mechanism including a plurality ofsensors interspersed along the length of the inner surface of at leastone of the skin pinching members so that the plurality of sensors faceinwards towards the side of the longitudinal fold of skin in use, theplurality of sensors being configured to detect pinching along a lengthof the longitudinal fold of skin and to confirm the uniformity of thelongitudinal fold of skin along its length.
 30. The needle deliverydevice according to claim 29, further comprising a pharmaceuticalcomposition delivery mechanism configured, in use, to deliver apharmaceutical composition through the needle.
 31. The needle deliverydevice according to claim 29, wherein the needle path changes directionas the needle path leaves the device body.
 32. The needle deliverydevice according to claim 29, further comprising at least one needle.33. The needle delivery device according to claim 32, wherein at least aportion of the at least one needle is flexible.
 34. The needle deliverydevice according to claim 32, further including a guide memberconfigured to guide the at least one needle along the needle path. 35.The needle delivery device of claim 34, wherein the guide member is, orincludes, a roller.
 36. The needle delivery device according to claim33, wherein the at least one needle is configured to revert to anelongated straight shape after passing through an arcing pathway. 37.The needle delivery device according to claim 32, wherein whenpositioned within the device body the at least one needle is covered bya protective sheath.
 38. The needle delivery device according to claim37, wherein the protective sheath has a rigid section and a flexiblesection, wherein the rigid section surrounds a tip of the at least oneneedle and comprises an opening to allow the at least one needle to exitthe rigid section on actuation of the drive mechanism.
 39. The needledelivery device according to claim 38, wherein the protective sheathcomprises a sealing membrane covering the opening, wherein the sealingmembrane is penetrable by the at least one needle.
 40. The needledelivery device according to claim 32, wherein the at least one needlehas a length of greater than about 12 mm.
 41. The needle delivery deviceaccording to claim 30, which comprises a pharmaceutical compositionreservoir in fluid communication with the pharmaceutical compositiondelivery mechanism.
 42. The needle delivery device of claim 29, whereinthe one or more skin pinching members are configured to automaticallyadjust based on a volume of a pharmaceutical composition to be injectedinto the skin; or wherein the plurality of sensors include pressuresensors, and wherein the one or more skin pinching members areconfigured to automatically adjust based on the pressure of the pinchedskin measured by the pressure sensors.
 43. The needle delivery deviceaccording to claim 29, wherein the plurality of sensors comprise atleast one light source and at least one light sensor to detect thepresence of pinched skin therebetween.
 44. The needle delivery deviceaccording to claim 29, wherein the plurality of a sensors comprise atleast one mechanical switch to detect contact with pinched skin.
 45. Theneedle delivery device according to claim 29, wherein the plurality ofsensors comprise an electrical sensor to detect contact with pinchedskin.
 46. The needle delivery device according to claim 29, wherein theplurality of sensors includes a pressure sensor.
 47. A method of sensingthe pinching of a longitudinal fold of skin comprising; placing a deviceof claim 29 in contact with the skin of a patient; moving at least oneskin pinching member to pinch a longitudinal fold of skin; and sensingthe pinching of the longitudinal fold of skin and confirming theuniformity of the longitudinal fold of skin along its length with the atleast one sensor mechanism.